The Senate committee, however, has stripped a provision from an earlier version of the bill that would have allowed inmates to get addiction medication — methadone or buprenorphine — regardless of whether they had a prescription before they were incarcerated. Currently, a prescription is a prerequisite. Staff from the Department of Health and the Department of Corrections have said they support this expansion but made the case that they aren't prepared to implement it right away.
The revised bill calls for a report on the topic and asks the DOC to develop a memorandum of understanding with local treatment providers by Dec. 31, 2018.
Tom Dalton, executive director of Vermonters for Criminal Justice Reform, protested the delay.
“They don’t need another extension. They don’t need another report,” he told the committee Tuesday. He asked the members to "consider the urgent need" and "recognize that the time for delays and half-measures is over."
Three influential senators introduced the bill: Senate President Pro Tempore Tim Ashe (D/P-Chittenden); Sen. Claire Ayer (D-Addison), who chairs the Health and Welfare Committee; and Sen. Dick Sears (D-Bennington), who chairs the Judiciary Committee.
Sears told the Institutions Committee that one of his relatives overdosed and died in a Baltimore warehouse, three days after getting out of jail. "The people with the highest rate of death from heroin overdose … are people who are just released from jail," he said. "That’s why I think it’s important that anybody who is willing to go through treatment be able to receive that treatment while incarcerated."
Ashe also testified, advocating for “the most aggressive schedule of meeting these individuals’ needs” but also telling the committee, “I’ll leave the judgment to you folks.”
If approved by the full Senate, the chair of House Corrections and Institutions Committee, Rep. Alice Emmons (D-Springfield) has said she plans to take it up.
Disclosure: Tim Ashe is the domestic partner of Seven Days publisher and coeditor Paula Routly. Find our conflict-of-interest policy here: sevendaysvt.com/disclosure.